Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of W0035 Ivermectin Suspension vs Stromectol
NCT03717558Phase 1Withdrawn
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ivermectin in Helminthic Infections (4 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Concentration of ivermectin. Planned start Apr 2018; status: withdrawn.
02
Drugs
ivermectin
03
Conditions
Helminthic Infections
Beyond the preview
Go deeper on NCT03717558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717558.